HEC CJ PHARM: JOINT ANNOUNCEMENT MONTHLY UPDATE PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE IN RELATION TO THE POSSIBLE MERGER OF THE COMPANY
Apr 8 05:34 ET
HEC CJ PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
Apr 2 05:09 ET
HEC CJ PHARM: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Mar 28 06:09 ET
HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code
Mar 21 04:36 ET
HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code
Mar 21 04:36 ET
HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code
Mar 20 04:52 ET
HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code
Mar 20 04:52 ET
HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code
Mar 19 05:08 ET
HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code
Mar 19 05:08 ET
HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code
Mar 18 04:34 ET
HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code
Mar 18 04:34 ET
HEC CJ PHARM: NOTICE OF BOARD MEETING
Mar 18 04:31 ET
HEC CJ PHARM: SUPPLEMENTAL ANNOUNCEMENT POSITIVE PROFIT ALERT
Mar 15 10:40 ET
HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code
Mar 14 04:49 ET
HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code
Mar 14 04:49 ET
HEC CJ PHARM: ANNOUNCEMENT POSITIVE PROFIT ALERT
Mar 12 10:39 ET
HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code
Mar 12 05:30 ET
HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code
Mar 12 05:30 ET
HEC CJ PHARM: EXCHANGE NOTICE - RESUMPTION OF TRADING
Mar 10 20:38 ET
HEC CJ PHARM: INSIDE INFORMATION IN RELATION TO A POSSIBLE TRANSFER OF SHARES IN THE COMPANY UNUSUAL PRICE MOVEMENTS ANNOUNCEMENT PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE AND INSIDE INFORMATION IN RELATION TO A POSSIBLE MERGER OF THE COMPANY AND RESUMPTI
Mar 8 05:31 ET
No Data
No Data